SPATIAL IMMUNE CELL PROFILING DETECTS DISEASE-SPECIFIC IMMUNE MICROENVIRONMENT IN IGG4-RELATED KIDNEY DISEASE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/ed08d54fb080c839c95a7155f4a6fd09.pdf
SPATIAL IMMUNE CELL PROFILING DETECTS DISEASE-SPECIFIC IMMUNE MICROENVIRONMENT IN IGG4-RELATED KIDNEY DISEASE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Satoshi
Hara
Satoshi Hara satoshihara@staff.kanazawa-u.ac.jp Kanazawa University Department of Nephrology and Rheumatology Kanazawa Japan * The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States
Junting Ai juntingai@uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States -
Thao Cao thaocao@uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States - The University of Chicago Pritzker School of Molecular Engineering Chicago United States
Madeleine Torcasso durkeems@uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States - The University of Chicago Pritzker School of Molecular Engineering Chicago United States
Bayard Walsh bkwalsh@uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States -
Arunava Nag Arunava.Nag@bsd.uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States -
Michael Andrade andradems@uchicago.edu The University of Chicago Department of Surgery Chicago United States -
Anthony Chang anthony.chang@bsd.uchicago.edu The University of Chicago Department of Pathology Chicago United States -
Marcus Clark mclark@bsd.uchicago.edu The University of Chicago Section of Rheumatology and Gwen and Jules Knapp Center for Immunology and Lupus Research, Department of Medicine Chicago United States -
-
-
-
-
-
-

IgG4-related kidney disease (IgG4-RKD) is a fibroinflammatory condition characterized by lymphoplasmacytic tubulointerstitial nephritis. The spatial organization within the immune microenvironment of IgG4-RKD remains poorly defined.

We applied high-dimensional confocal microscopy using co-detection by indexing with a 54-marker antibody panel to kidney biopsy specimens from patients with IgG4-RKD (n = 7), ANCA-associated vasculitis (AAV, n = 9), and control kidneys (n = 4). Cells were segmented with a fine-tuned Cellpose 2.0 pipeline, and cell classification was performed by pseudo-spectral angle mapping (pSAM) with 59 membrane and 16 nucleus classes. pSAM cell prediction performance was also assessed using 2,947 ground-truth-annotated cells from IgG4-RKD. Structural segmentation based on a fine-tuned U-Net and Omnipose was also applied to determine the location of each cell in the kidney structure. Immune cell proportions and densities were compared among groups, followed by correlation and neighborhood analyses to identify disease-specific immune microenvironments.

A total of 889,919 cells were segmented from whole-kidney tissues across all samples. pSAM accurately classified immune cell types with weighted-average F1 scores of 0.88. Structural segmentation confirmed that almost all of the immune cells in IgG4-RKD were in the interstitial compartment, while up to 20% of those in AAV were in the tubular compartment. Thus, we focused on 369,949 cells in interstitial areas for downstream analyses. Myeloid cells were the most frequent immune population in both diseases, but CD8⁺T cells were significantly enriched in IgG4-RKD. Distinct immune subsets in IgG4-RKD included HLA-II⁺granzyme K⁺ICOS+PD-1+CD4+T follicular helper (Tfh) cells, HLA-II⁺CD27⁺CD4⁺Foxp3+regulatory T cells (Tregs), CD8⁺Foxp3+Tregs, CD11c⁺B cells, and MerTK⁺CD68+M1-like macrophages. In contrast, AAV was characterized by TCF1⁺TOX⁻ stem-like CD4⁺T/CD8⁺T cells, CD68+CD163+M2-like macrophages, and CD16-CD56+immature natural killer cells. Spearman’s correlation analysis demonstrated broader interlineage associations among CD4⁺T, CD8⁺T, humoral, myeloid, and myofibroblasts in IgG4-RKD, whereas correlations in AAV were largely confined to CD4⁺ and CD8⁺ T cell compartments. Density-based spatial clustering of applications with noise, followed by Louvain community detection, identified 20 unique immune/myofibroblast niches. IgG4-RKD–enriched niches included: (1) CD69+CD4⁺/CD8⁺ tissue-resident memory T cells with ICOS+PD-1+CD4+Tfh cells and CD11c-CD27-CD20+T-bet+double-negative type 3 B cells; (2) granzyme B⁺CD8⁺cytotoxic T lymphocytes with CD8⁺Foxp3+Tregs and γδT cells; and (3) glycoprotein-NMB (GPNMB)⁺CD68⁺M1-like and GPNMB+CD68+CD163+M2-like macrophages. AAV-enriched niches included: (1) CD4⁺Foxp3+Tregs, Th1 cells, and TIGIT⁺CD8⁺T cells; (2) CD68+CD163+M2-like macrophages, CD90⁺αSMA+myofibroblasts, and CD68⁺CD163⁺αSMA+macrophage–mesenchymal transition cells; and (3) CD11b+CD16+myeloperoxidase (MPO)+neutrophils and MPO⁺CD68⁺macrophages.

Spatial immune profiling reveals distinct immune microenvironments in IgG4-RKD, characterized by unique CD4⁺/CD8⁺T cell, B cell, and macrophage subsets, along with broader intercellular correlations. These findings provide novel insights into disease pathogenesis and may inform future therapeutic strategies.

Kewords